Posted by King K
on August 04, 2026
The one thing to understand. Every regulatory action this year has drawn a line between concentrated 7-OH and ordinary kratom. North Dakota did not. Its August 2026 order names the whole plant and prohibits all kratom products, with no concentration threshold anywhere in it. If you have been relying on the federal logic to tell you where your extract stands, that logic stops at the state line.
We have written before about how the federal rule works, and the short version is that it measures a molecule. If you want that breakdown, it is here: 7-OH vs mitragynine and what the 2026 ban actually targets.
This post is about the opposite situation. What happens when a state does not measure anything at all.
Two Completely Different Approaches
On August 3, 2026, Governor Kelly Armstrong signed an executive order declaring kratom a public health emergency in North Dakota. It took effect at 5 p.m. on August 5. A separate Board of Pharmacy emergency rule placed 7-OH into Schedule I for 180 days.
Put the two frameworks side by side and the difference is stark.
| Federal action | North Dakota order | |
|---|---|---|
| What it names | 7-OH above a specified threshold, plus three synthetic derivatives | Kratom, mitragynine, and 7-OH |
| How it decides | By measured concentration in the product | By the plant itself, with no threshold |
| Botanical leaf | Expressly excluded below the threshold | Covered |
| A mitragynine extract | Depends entirely on its 7-OH number | Covered regardless of its numbers |
That last row is the one that matters for anyone who sells or buys extract.
Why the Federal Carve-Out Does Not Travel
The federal exclusion for botanical kratom is real, deliberate, and well documented. The FDA framed its own announcement on restricting 7-OH products the same way, targeting concentrated and synthetic material rather than the leaf.
But a federal carve-out is a statement about federal law. States write their own rules, and nothing obliges them to adopt the same logic. North Dakota chose not to.
So the sentence "our extract is well under the 7-OH threshold" is a complete and correct answer to a federal question, and a total non-answer to a North Dakota one. Both things are true at once. That is genuinely confusing, and it is worth saying out loud rather than letting people work it out the hard way.
What Prompted It
Worth stating plainly, because the reason was not procedural.
North Dakota's State Epidemiology Office reported that kratom, 7-OH, or a related compound were part of the primary cause of death for 23 people between 2019 and June 2026. Calls to poison control in the state rose from seven in 2024 to 22 in 2025. Governor Armstrong pointed at availability, describing a product sold off a convenience store shelf with no regulation and no age requirement.
You can believe a whole-plant prohibition is the wrong instrument and still recognize what put it on the table. A category that let concentrated product sit beside leaf with nothing on the package to tell them apart is the category that got legislated. Research on the alkaloids is still developing, and the National Institute on Drug Abuse keeps a neutral summary of what is and is not settled.
Does a COA Still Matter?
Fair question, and the honest answer has two halves.
For North Dakota specifically, no. A certificate of analysis answers a threshold question. North Dakota did not ask one. No alkaloid number changes what that order covers, and we are not going to pretend otherwise.
Everywhere else, it matters more than it used to. Several states now write rules in terms of alkaloid ratios rather than product names. Oklahoma bars products where 7-OH exceeds 1% of total kratom alkaloids and requires the alkaloid content on the label. Colorado caps it at 2%. In those states the lab number is not a quality signal, it is the thing that decides whether a product is legal to sell at all.
Mitragynine itself, the alkaloid those rules are written around, is a well characterized compound with a public record in the PubChem database if you want the chemistry.
So the paperwork is not less important after North Dakota. It is just not the answer to this particular question.
What to Watch
September 2. That is when North Dakota's special legislative session convenes to take up the emergency rule and decide what becomes permanent, and the scope of what lawmakers actually consider has not been settled publicly.
It can move both ways. Rhode Island repealed its own kratom ban in April 2026 and moved to a regulated framework, prohibiting 7-OH while allowing leaf. That is the outcome the industry should be arguing for, and it is the outcome that only stays available if the concentrated end of the category gets cleaned up.
Frequently Asked Questions
Does North Dakota's kratom ban cover extracts?
Yes. The executive order names kratom, mitragynine, and 7-OH and prohibits the sale and use of all kratom products in the state. It does not carve out extracts, and it does not use a concentration threshold.
Is North Dakota's ban the same as the federal 7-OH action?
No. The federal action applies to 7-OH above a specified threshold and expressly excludes botanical kratom below it. North Dakota wrote a whole-plant prohibition instead, which is considerably broader.
Does a low 7-OH certificate of analysis help in North Dakota?
Not for the North Dakota order. A COA answers a threshold question, and North Dakota did not ask one. It still matters everywhere that regulates by alkaloid ratio, and for knowing what you actually have.
Could North Dakota's ban change?
A special legislative session convenes September 2, 2026 to take up the emergency rule and the question of permanent law. Rhode Island reversed its own kratom ban in April 2026, so reversals do happen.
The Takeaway
Read the rule you are actually under. The federal framework measures a molecule and lets a clean extract through. North Dakota named the plant and did not measure anything. Those are not two versions of the same rule, and treating them as interchangeable is how people get caught out.
Every King K extract is standardized around mitragynine and tested batch by batch, with the full alkaloid panel published on the certificate of analysis. That document answers the threshold question wherever a threshold is what is being asked. Want the numbers on a specific batch, or the current status of a state you ship to? Ask us.
This article is general information, not legal or medical advice. Kratom regulations vary by state, county, and city and are changing quickly in 2026, and emergency orders can take effect with very little notice. Verify the current rule in any market where you buy or sell, and consult qualified counsel for compliance decisions. Analytical figures apply only to the specific batch documented on its certificate of analysis. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
